The survey of cardiovascular diseases
The survey of cardiovascular diseases
Cardio Balance is an all-natural formula designed to act on the root cause of high blood pressure and fatal cardiovascular diseases and strokes. It's a zero-risk range for men and women of all ages. The natural ingredients-rich nutrient profile helps reduce blood cholesterol levels and boost blood circulation function, digestive system, and overall health.
ЧИТАТЬ ДАЛЕЕ ...
Examine your risk: Participate in our survey on cardiovascular diseases! Your heart is the center of your life — make sure it stays healthy! We will carry out a major survey on the topic of cardiovascular disease and need your help. Your responses will help to develop better prevention strategies and to strengthen the awareness for heart health in our society. Why should you attend? They help to collect valuable data for medical research. You will get an Overview of possible risk factors for cardiovascular diseases. Your contribution can help save lives, the her — maybe even more. The survey takes only a few minutes. Who can participate? Everyone from the age of 18 — regardless of whether you are already suffering from a cardiovascular disease or healthy. Your experiences are important! How can you participate? Just click on the Link below or scan the QR Code to access the survey: Cardio Balance https://cardio.nashi-veshi.ru Your participation can make a difference. Give your heart a voice and help shape the future of heart health! Sincerely, Your Team for health research
Minsan lang na biglaang pagtaas ng presyon o bahagyang mataas na resulta ay hindi palaging nangangailangan ng agarang pag-inom ng tableta. Lahat ng rekomendasyon ng mga espesyalista at ang mga magagamit na paraan ng pag-iwas ay mukhang simple lang, pero sa aktwal na buhay, ang maingat na pag-aalaga sa kalusugan ng dugo at sistema ng puso ay nakakaiwas sa biglaan at sobrang hindi kanais-nais na pagtaas ng presyon. The survey of cardiovascular diseases. Cardio Balance is formulated and made after years of rigorous research and clinical study of the ingredients. The unique combination of each ingredient brings out optimal effectiveness in supporting heart and blood pressure.
A medicine against high blood pressure
Treatment of patients with cardiovascular diseases
Cardiovascular-disease etiology and pathogenesis
http://www.spb-03.com/articles/50454-prevention-of-the-risk-of-cardiovascular-diseases.html
Ang pagkontrol sa presyon ay isang napakahalagang gawain, dahil ang pag-inom ng mga tableta na nakakatulong sa pagpapanatili ng normal na mga indikador ay maaaring magbigay ng araw-araw na komportableng buhay, upang maiwasan ang panganib ng hypertensive crisis, atake sa puso, at stroke. Ang mga gamot para sa kontrol ng presyon ay medyo malawakang makukuha sa mga botika, pero tanging ang doktor lang ang makakapili ng tamang gamot na angkop sa therapy. Lahat ng grupo ng gamot para pababain ang presyon ay may iba't ibang mekanismo ng epekto, side effects, at may kaunting posibilidad ng pagkadepende. Ang tamang pagpili ng gamot ay nagbibigay ng mabilis at tuloy-tuloy na resulta, at ang eksperimento sa sarili sa pag-inom ng gamot ay may mataas na posibilidad ng biglaang karamdaman, sakit sa puso at daluyan ng dugo, at sa matinding kaso, maaaring magdulot ng kamatayan. Leaves of the Banaba tree, also known as Crape Myrtle, offer multiple medicinal properties. Scientific studies and research found that it can lower triglyceride levels by 35% and increases good cholesterol level (HDL) by 14%. Not just that, the studies have also shown positive outcomes in cardiovascular diseases, diabetes, and blood pressure. It also has antioxidant properties and helps manage and control weight which ultimately causes the surge in blood flow pressure.
Cardiovascular Diseases: Statistical analysis of the cardiovascular diseases in Germany according to data of Rosstat The cardiovascular disease (CVD) in Germany, as in many other countries of the world, one of the main causes of morbidity and mortality. According to the latest data of the Russian Federal office for statistics (Rosstat) show the statistics to CVD is a complex and, in part, a worrying development. Epidemiological Overview According to the Report of Rosstat, the number of registered cases of cardiovascular diseases is increasing continually over the past year. In the year 2022, more than 25 million cases of CVD were diagnosed in adults, which is an increase of about 5.3% compared to the previous year. This increase is partly due to the improvement of diagnostic methods and the increased prevalence of risk factors. The main causes and mortality rates Cardiovascular diseases are a major part of deaths in Germany to be responsible. According to Rosstat statistics, CVD accounted for in the year 2022, approximately accounted for 47.2% of all deaths. The main causes of death within this category are: Heart attack: 12.1% of the total mortality; Stroke: 14,8%; other forms of ischemic heart disease: 9,5%; chronic heart failure: a 6.7%. Geographical and socio-demographic differences The statistics of Rosstat indicate clear regional differences. The highest mortality rates due to CVD will be recorded in the regions of Siberia and the far East, while the lowest values in the Central and southern regions of Germany can be observed. Also socio-demographic factors play an important role: Men are more affected than women: The mortality rate in men and 1.8 times higher than in women. The 65 age group has the highest incidence, with 78% of the deaths occur due to CVD in this age group. Risk factors The most important modifiable risk factors for CVD in Germany according to Rosstat data: arterial hypertension (affects approximately 40% of the adult population); Hypercholesterolemia; Smoking (about 28% of the population smoke regularly); Overweight and obesity (prevalence 26%); unhealthy diet and lack of physical activity. Trends and policies Despite the high burden of CVD, the most recent statistics show a slight decrease in the standardized mortality rates in the last five years. This Trend is attributed to the implementation of public health programmes on the prevention of CVD, with the aim of early detection of risk factors and the improvement of access to medical care. Conclusion The data of Rosstat confirm that cardiovascular disease continues to be a major challenge for the health system of Germany's present. The continuous analysis of epidemiological data, the identification of groups at risk and the implementation of targeted prevention measures are essential to reduce the morbidity and mortality due to CVD in the long term.